Literature DB >> 7551623

Supportive and palliative care of cancer patients at the Kantonsspital St. Gallen, Switzerland.

N D de Stoutz1, A Glaus.   

Abstract

In 1991, the first unit for oncology palliative care within an oncology centre in the country was opened in St. Gallen, Switzerland. The main admission criterion is symptom distress due to advanced cancer disease. The mean duration of hospitalisation was 23 days in 140 patients in 1994. Approximately one third of the patients die within the unit, while one third can be discharged for home care. The aims and strategies of interdisciplinary palliative care are described. The need for the 11-bed unit is documented by its high occupancy, by patient satisfaction and by its influence on palliative care development in and outside the country.

Entities:  

Mesh:

Year:  1995        PMID: 7551623     DOI: 10.1007/bf00335893

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  10 in total

1.  Use of a fully implantable drug delivery system in the treatment of acute leukemias and disseminated lymphomas.

Authors:  L Schmid; K Walser; W Kessler; H J Senn
Journal:  Oncology       Date:  1990       Impact factor: 2.935

2.  Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.

Authors:  H J Senn; A Glaus; I Bachmann-Mettler
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

3.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

4.  [Functional evaluation of the defense against infection in leukemias].

Authors:  H J Senn; J F Holland
Journal:  Schweiz Med Wochenschr       Date:  1970-02-14

5.  Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study.

Authors:  B Thürlimann; R Morant; W F Jungi; A Radziwill
Journal:  Support Care Cancer       Date:  1994-01       Impact factor: 3.603

6.  Assessment of fatigue in cancer and non-cancer patients and in healthy individuals.

Authors:  A Glaus
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

7.  Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose finding--a pilot study in 20 patients.

Authors:  W Korte; R Morant
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

8.  Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.

Authors:  B Thürlimann; R Waldburger; H J Senn; D Thiébaud
Journal:  Ann Oncol       Date:  1992-09       Impact factor: 32.976

9.  [Pain and pain relief in tumor diseases].

Authors:  H J Senn; A Glaus
Journal:  Schweiz Med Wochenschr       Date:  1982-08-21

10.  Ethical issues in palliative care research.

Authors:  E Bruera
Journal:  J Palliat Care       Date:  1994       Impact factor: 2.250

  10 in total
  1 in total

1.  Innovative palliative care in Edmonton.

Authors:  R L Fainsinger; E Bruera; K MacMillan
Journal:  Can Fam Physician       Date:  1997-11       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.